Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Videos

Kimberly Skylstad, PharmD, Discusses Improving Compliance, Care With Pharmacist Integration Into Primary Care

09/07/2019

 

Kimberly Skylstad, BS, PharmD, MPH, assistant professor of pharmacy practice at Albany College of Pharmacy and Health Sciences, discusses recent research that is aimed at ensuring that a pharmacist is integrated into a patient’s primary care team to help improve outcomes. 

To view Dr Skylstad's poster, click here.

Advertisement

Advertisement

Advertisement

What's Trending?

AGS Viewpoint
AGS Commends Proposed Medicare Policies to Improve Care for Chronically Ill Older Adults
08/15/2016

American Geriatrics Society (AGS)

American Geriatrics Society (AGS) ...
CMS proposes making payment for a number of services provided to chronically ill older adults—changes which, when finalized, will dramatically improve current payment for chronic care management and assessment as well as care planning for...
CMS proposes making payment for a number of services provided to chronically ill older adults—changes which, when finalized, will dramatically improve current payment for chronic care management and assessment as well as care planning for...
CMS proposes making payment for...
08/15/2016
Annals of Long-Term Care
News
Payers Urge CMS to Update Biosimilar Payment Policies
09/22/2017
Lobby groups have urged the CMS to make changes that could improve savings for patients and health care payers, as well as expand patient access to biosimilars.
Lobby groups have urged the CMS to make changes that could improve savings for patients and health care payers, as well as expand patient access to biosimilars.
Lobby groups have urged the CMS...
09/22/2017
First Report Managed Care
News
Baxter Recalls Potassium Chloride Injection
09/18/2014
On Wednesday, the U.S. Food and Drug Administration (FDA) announced that Baxter International is recalling one lot of potassium chloride injection (10 mEq per 100 mL).
On Wednesday, the U.S. Food and Drug Administration (FDA) announced that Baxter International is recalling one lot of potassium chloride injection (10 mEq per 100 mL).
On Wednesday, the U.S. Food and...
09/18/2014
Pharmacy Learning Network
News
FDA Accepts Dupixent sBLA for Priority Review
03/11/2019
The FDA has accepted a supplemental Biologics License Application (sBLA) for Dupixent (dupilumab; Sanofi, Regeneron) as an add-on maintenance treatment for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps.
The FDA has accepted a supplemental Biologics License Application (sBLA) for Dupixent (dupilumab; Sanofi, Regeneron) as an add-on maintenance treatment for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps.
The FDA has accepted a...
03/11/2019
First Report Managed Care
News
Federal Court Says Promoting Off-Label Drug Use Protected By Free Speech
08/25/2015
Pharmaceutical companies may now be able to provide truthful and non-misleading information about the off-label use of drugs already approved by the FDA after a recent U.S. district court ruling.
Pharmaceutical companies may now be able to provide truthful and non-misleading information about the off-label use of drugs already approved by the FDA after a recent U.S. district court ruling.
Pharmaceutical companies may now...
08/25/2015
Pharmacy Learning Network

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement